Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nagyeom, Lee"'
Publikováno v:
Kosin Medical Journal, Vol 38, Iss 1, Pp 36-42 (2023)
Background Nafamostat mesylate is widely used as an anticoagulant in continuous renal replacement therapy (CRRT). The generic versions of nafamostat mesylate have identical main components to the original product. However, it is questionable whether
Externí odkaz:
https://doaj.org/article/025a85ced82e49dd9084ecef65b9b208
Autor:
Nagyeom Lee, Sooyoung Lim
Publikováno v:
KIEAE Journal. 23:31-36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01ba9095d627e6806fb56a79cd8dd7d4
https://doi.org/10.12813/kieae.2023.23.2.031
https://doi.org/10.12813/kieae.2023.23.2.031
Autor:
Sujung, Heo, Youngchan, Park, Nagyeom, Lee, Yanghyeon, Kim, Ye Na, Kim, Ho Sik, Shin, Yeonsoon, Jung, Hark, Rim, Helmut G, Rennke, Anil, Chandraker
Publikováno v:
Transplantation Proceedings. 54:2117-2124
We evaluated the efficacy and safety of eculizumab in comparison with plasmapheresis and intravenous immunoglobulin therapy in renal transplant recipients diagnosed with antibody-mediated rejection (AMR).This was a multicenter, open-label, prospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6e09a26f500b9d8ac3fcf48129e81cb
https://doi.org/10.1016/j.transproceed.2022.08.008
https://doi.org/10.1016/j.transproceed.2022.08.008
Autor:
Nagyeom Lee, Sooyoung Lim
Publikováno v:
KIEAE Journal. 21:91-97
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9086c5cb3cd23b0059c71e1e6a236a2c
https://doi.org/10.12813/kieae.2021.21.4.091
https://doi.org/10.12813/kieae.2021.21.4.091
Publikováno v:
Transplantation. 106:S627-S627
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b0d9bf89cf6f0821fdffe059a271c52
https://doi.org/10.1097/01.tp.0000888960.13263.3c
https://doi.org/10.1097/01.tp.0000888960.13263.3c